Aurobindo Pharma gets USFDA approval for generic version of Revatio drug

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator’s website.

The medication is a generic version of Revatio oral suspension by Viatris Inc. It is prescribed to adults to treat pulmonary arterial hypertension and to improve their exercise capacity.

Shopping Cart
Scroll to Top